1 November 2020 in Journal of Hepatology
ICInternational Variceal Bleeding Observational Study Group and Baveno Cooperation
International Variceal Bleeding Observational Study Group and Baveno Cooperation
+57
The relationship between acute-on-chronic liver failure (ACLF) and acute variceal bleeding (AVB) is poorly understood. Specifically, prevalence and prognosis of ACLF in AVB is unclear, while the role of transjugular intrahepatic porto-systemic shunt (TIPS) in the management in ACLF patients has not been described to date. A multicenter, international, observational study was conducted including 2138 patients from 34 centers between 2011 and 2015. ACLF was defined and graded according to the EASL-CLIF consortium definition. Placement of pre-emptive TIPS (pTIPS) was based on individual center policy. Patients were followed up to one year, until death or liver transplantation. Cox regression model and competing risk models (Gray's test) were used to identify independent predictors of rebleeding or mortality. At admission, 380/2138 (17.8%) patients had ACLF according to EASL-CLIF criteria (grade-I:38.7%; II:39.2%; III:22.1%). Forty-two day rebleeding rate (19% vs. 10%; p<0.001) and mortality (47% vs. 10%; p<0.001) were higher in patients with ACLF and increased with ACLF grades. Of note, presence of ACLF was independently associated with rebleeding and mortality. pTIPS placement improved survival in ACLF patients at 42 days and one year. This effect was also observed in propensity score matching analysis of 44 ACLF patients without pTIPS and 22 ACLF patients with pTIPS. This large multi-center international real-life study identified ACLF as at admission an independent predictor of rebleeding and mortality in AVB. Moreover, pTIPS improves survival in patients with ACLF and AVB. Therefore, pTIPS may be considered in ACLF patients with AVB, although the presented data need to be independently validated.
2 September 2022 in Journal of Hepatology
14 June 2020 in World Journal of Gastroenterology
Diagnostic challenges in non-cirrhotic portal hypertension - porto sinusoidal vascular disease
1 December 2019 in Digestive and Liver Disease